Population
Myocardial fibrosis in various cardiac diseases, including myocardial infarction, hypertensive heart…
Design
Review
Authors
Loading...
May offer adjunctive options for MF with limited therapies; extends preclinical signals but requires confirmatory RCTs.
Natural compounds show therapeutic potential for myocardial fibrosis by regulating profibrotic signaling pathways, though clinical translation requires further pharmacokinetic and clinical trial data.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: